Právní předpis byl sestaven k datu 25.08.2024.
Zobrazené znění právního předpisu je účinné od 01.10.2015.
Nařízení vlády, kterým se mění nařízení vlády č. 463/2013 Sb., o seznamech návykových látek
243/2015 Sb.
Účinnost Čl. III
243
XXXXXXXX VLÁDY
ze xxx 14. září 2015,
kterým xx xxxx xxxxxxxx xxxxx x. 463/2013 Xx., o xxxxxxxxx xxxxxxxxxx xxxxx
Xxxxx xxxxxxxx xxxxx §44c odst. 1 zákona x. 167/1998 Xx., x xxxxxxxxxx xxxxxxx x x xxxxx některých xxxxxxx xxxxxx, ve xxxxx xxxxxx x. 273/2013 Sb.:
Xx. X
Xxxxxxx x. 4 k nařízení xxxxx č. 463/2013 Sb., x xxxxxxxxx návykových xxxxx, xxx:
"Xxxxxxx č. 4 x xxxxxxxx xxxxx x. 463/2013 Xx.
Xxxxxxxxxxx xxxxxxxxxx xxxxx (XXX) x xxxxxx xxxxxx |
Xxxxx xxxxxxxxxxx xxxxxxxxxx název xxxx obecný xxxxx |
Xxxxxxxx xxxxx xxxxx XXXXX |
Xxxxxxxx |
XX-7921 |
3,4-xxxxxxx-X-{[1-(xxxxxxxxxxxxx)xxxxxxxxxx)]xxxxxx}xxxxxxxx |
||
XX-2201 |
[1-(5-xxxxxxxxxxx)-1X-xxxxx-3-xx](xxxxxxxx-1-xx)xxxxxxxx |
||
5-XX1 |
5-(2-xxxxxxxxxxx)xxxxx |
||
XXXXXXX |
X-(xxxxxxxxx-1-xx)-1-xxxxxx-1X-xxxxxxx-3-xxxxxxxxxx |
||
xx-XXX |
2-xxxxx-1-(4-xxxxxxxxxxxx)xxxxxx-1-xx |
||
xx-XXXX |
1-(4-xxxxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
||
25X-XXXXx |
2-(4-xxxx-2,5-xxxxxxxxxxxxxx)-X-[(2-xxxxxxxxxxxx)xxxxxx]xxxxxxxxx |
||
Xxxxxxxxxxxxx |
XXX |
(2XX)-1-(4-xxxx-2,5-xxxxxxxxxxxxxx)xxxxxx-2-xxxx |
|
Xxxxx-Xxxxxxxxx |
1-(8-xxxxxxxxx[1,2x:4,5-x´]xxxxxxx-4-xx)xxxxxx-2-xxxx |
||
Xxxxxxx |
2-(xxxxxxxxxxx)-1-[3,4-(xxxxxxxxxxxxx)xxxxx)]xxxxx-1-xx |
||
Xxxxxxxxxxxxxxxxxxxxxxxx |
2X-X |
(4-xxx-2,5-xxxxxxxxxxxxxxxxx)xxxx |
|
25X-XXXXx |
2-(4-xxxxx-2,5-xxxxxxxxxxxxxx)-X-[(2-xxxxxxxxxxxx)xxxxxx]xxxxxxxxx |
||
Xxxxxxxxxxxxxxxxxxxxxxxxxxxxxx |
2X-X-2 |
[4-(xxxxxxxxxxxxx)-2,5-xxxxxxxxxxxxxxxxx]xxxx |
|
Xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx |
2X-X-7 |
[2,5-xxxxxxxxx-4-(xxxxxxxxXxxxxx)xxxxxxxx]xxxx |
|
XX-47,497 |
2-[(1X,3X)-3-xxxxxxxxxxxxxxxxx]-5-(2-xxxxxxxxxxx-2-xx)xxxxx |
||
XXX-13 |
(xxxxxxxx-1-xx)[4-(xxxxxxxxx)xxxxxxxx-1-xx]xxxxxxxx |
||
XXXX |
1,4-xxxxxxxxxxxxxxxxx |
||
Xxxxxxxxxxxxxxxx |
XXX |
X,X-xxxxxxx-X-[2-(xxxxx-3-xx)xxxxx]xxxx |
|
Xxxxxxxxxxxxxxxxxx |
XXX |
(2XX)-1-(2,5-xxxxxxxxxxxxxx)xxxxxx-2-xxxx |
|
4,4'-XXXX |
4-xxxxxx-5-(4-xxxxxxxxxxx)-4,5-xxxxxxx-1,3-xxxxxx-2-xxxx |
||
Xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx |
XXXX |
3-(1,2-xxxxxxxxxxxxxx)-6,6,9-xxxxxxxxx-7,8,9,10-xxxxxxxxxx-6X-xxxxx[x] xxxxxxx-1-xx |
|
3,4-XXXX |
1-(3,4-xxxxxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
||
Xxxxxxxxxxxxxxxxx |
XXX |
X[2-(xxxxx-3-xx (xxxxx]-X,X-xxxxxxxxxxxx |
|
XXX |
1-(4-xxxxx-2,5-xxxxxxxxxxxxxx)xxxxxx-2-xxxx |
||
Xxxxxxxxxxxxxxxxxxxxxxx |
XXXX |
(2XX)-1-(4-xxxxx-2,5-xxxxxxxxxxxxxx)xxxxxx-2-xxxx |
|
XXx |
1-(4-xxx-2,5-xxxxxxxxxxxxxx)xxxxxx-2-xxxx |
||
Xxxxxxxxxxx |
XXX |
X-xxxxx-1-xxxxxxxxxxxxxxxxxxx |
|
Xxxxxxxxxx |
3-(2-xxxxxxxxxx)xxxxx |
||
4-XX |
1-(4-xxxxxxxxxx)xxxxxx-2-xxxx |
||
5X-XXX48 |
X-(xxxxxxxxx-1-xx)-1-(5-xxxxxxxxxxx)-1X-xxxxxxx-3-xxxxxxxxxx |
||
Xxxxxxxxx |
1-(4-xxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
||
4-XXX |
1-(4-xxxxxxxxxx)-X-xxxxxxxxxxxx-2-xxxx |
||
3-XXX |
1-(3-xxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
||
5XXX-144 |
[1-(5-xxxxxxxxxxx)-1X-xxxxx-3-xx](2,2,3,3-xxxxxxxxxxxxxxxxxxxxxx)xxxxxxxx |
||
251-XXXXx |
2-(4-xxx-2,5-xxxxxxxxxxxxxx)-X-[(2-xxxxxxxxxxxx)xxxxxx]xxxxxxxxx |
||
XXX-018 |
(xxxxxxxx-1-xx)(1-xxxxxx-1X-xxxxx-3-xx)xxxxxxxx |
||
XXX-073 |
(1-xxxxx-1X-xxxxx-3-xx)(xxxxxxxx-1-xx)xxxxxxxx |
||
XXX-081 |
(4-xxxxxxxxxxxxxxx-1-xx)(1 -xxxxxx-1X-xxxxx-3-xx)xxxxxxxx |
||
XXX-122 |
(4-xxxxxxxxxxxxxx-1-xx)(1-xxxxxx-1X-xxxxx-3-x)xxxxxxxx |
||
XXX-200 |
[1-(2-xxxxxxxxxxxxxx)-1X-xxxxx-3-xx](xxxxxxxx-1-xx)xxxxxxxx |
||
XXX-250 |
2-(2-xxxxxxxxxxxx)-1-(1-xxxxxx-1X-xxxxx-3-xx)xxxxx-1-xx |
||
XXX-398 |
(4-xxxxxxxxxxxxx-1-xx)(1-xxxxxx-1X-xxxxx-3-xx)xxxxxxxx |
||
Xxxxxxxx |
(2X)-2-xxxxx-1-xxxxxxxxxxx-1-xx |
||
(+)-Xxxxxxxx |
XXX, XXX-25 |
(+)-8β-(3,3-xxxxxxxxxxxxxx)-6-xxxxxx-9,10-xxxxxxxxxxxxxxxx |
|
4-Xxxxxxxxxxxx |
(2XX)-1-(4-xxxxxxxxxxx)xxxxxx-2-xxxx |
||
XXXX |
1-xxxxxx-4-xxxxxxxxxxxxxxx |
||
xXXX |
1-(3-xxxxxxxxxx)xxxxxxxxx |
||
XXXX |
5,6-(xxxxxxxxxxxxx)xxxxx-2-xxxx |
||
XXXX |
1-[3,4-(xxxxxxxxxxxxx)xxxxx]-2-(xxxxxxxxxx-1-xx)xxxxxx-1-xx |
||
3-XXX |
2-(xxxxxxxxxx)-1-(3-xxxxxxxxxxx)xxxxxx-1-xx |
||
4-XXX |
2-(xxxxxxxxxx)-1-(4-xxxxxxxxxxx)-xxxxxx-1-xx |
||
Xxxxxxxx |
2-(xxxxxxxxxxx)-1-(4-xxxxxxxxxxx)xxxxxx-1-xx |
||
Xxxxxxxx |
3,4,5-xxxxxxxxxxxxxxxxxxxxxxx |
||
Xxxxxxxxxxxx |
Xxxxxxx |
(2XX)-1-xxxxx-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
3-XXX |
2-(xxxxxxxxxxx(-1-(3-xxxxxXxxxxx)xxxxxx-1-xx |
||
Xxxxxxxxxxxxxxxxxxx |
XXXX |
(2XX)-1-[5-xxxxxxx-3,4-(xxxxxxxxxxxxx)xxxxx]xxxxxx-2-xxxx |
|
Xxxxxxxxxxxxxx |
(±)-5-xxxxx-4-xxxxxx-4,5-xxxxxxxxxxxxx-2-xxxxx |
||
Xxxxxxxxxxxxxxxxxx |
XXXX |
(2XX)-X-xxxxxx-1-[3,4-(xxxxxxxxxxxxx)xxxxx]xxxxxx-2-xxxx |
|
3-XxX-XXX |
1-[1-(3-xxxxxxxxxxxxx)xxxxxxxxxx]xxxxxxxxx |
||
xxxxxxxxxxxxx |
2-(xxxxxxxxxx)-2-(3-xxxxxxxxxxxx)xxxxxxxxxxxx |
||
Xxxxxxxx |
2-(xxxxxxxxxxx)-1-[3,4-(xxxxxxxxxxxxx)xxxxx]xxxxxx-1-xx |
||
XX-45 |
1-xxxxxxxxxx-4-(1,2-xxxxxxxxxxxx)-xxxxxxxxx |
||
Xxxxxxxxxxxxxxxxxxx |
4-XXX |
(2XX)-1-[4-(xxxxxXxxxxxxxx)xxxxx]xxxxxx-2-xxxx |
|
Xxxxxxx |
1-(xxxxxxxx-2-xx)-2-(xxxxxxxxxx-1-xx)xxxxxx-1-xx |
||
Xxxxxxxxxxxxxxxxx |
XXX, XXXX |
(2XX)-X-xxxxx-1-[3,4-(xxxxxxxxxxxxx)xxxxxxxxxxxx-2-xxxx |
|
Xxxxxxxxxxxxxxxxxxx |
(2XX)-X-xxxxxxx-1-[3,4-(xxxxxxxxxxxxx)xxxxx]xxxxxx-2-xxxx |
||
Xxxxxxxxxx |
3-xxxxx-6,6,9-xxxxxxxxx-7,8,9,10-xxxxxxxxxx-6X-xxxxx[x]xxxxxxx-1-xx |
||
xxxxxxxxx |
1-xxxxx-2-(xxxxxxxxxxxx)xxxxxx-1-xx |
||
xXXX |
1-(4-xxxxxxxxxx)xxxxxxxxx |
||
Xxxxxxxxxxxxxxxx |
XXX |
(2XX)-1-(4-xxxxxxxxxxxx)xxxxxx-2-xxxx |
|
Xxxxxxxxxxxxxxxxxxx |
XXXX |
1-(4-xxxxxxxxxxxx)-X-xxxxxxxxxxxx-2-xxxx |
|
Xxxxxxxxxx |
3-[2-(xxxxxxxxxxxxx)xxxxx]-1X-xxxxx-4-xx-xxxxxxxxxx-xxxxxx |
||
Xxxxxxxx |
Xxxxxxxxx |
3-[2-(xxxxxxxxxxxxx)xxxxx]-1X-xxxxx-4-xx |
|
Xxxxxxxxxxxx |
XXX, PCPY |
1-(1-fenylcyklohexyl)pyrrolidin |
|
α-PVP |
1-fenyl-2-(pyrrolidin-1-yl)-1-pentan-1-on |
||
Salvinorin X |
xxxxxx-(2XX,4xX,6xX,7X,9XX,10xXX,10xX)-9-xxxxxxx-2-(xxxxx-3-xx)-6x, 10x-xxxxxxxx-4,10-xxxxxxxxxxxxxxxx-1X-xxxxx[x]xxxxxxxxxx-7-xxxxxxxxxx |
||
Xxxxxxxxxxxxxxxxxxxxx |
XXX, DOM |
(2RS)-1-(2,5-dimethoxy-4-methylfenyl]propan-2-amin |
|
Tenamfetamin |
MDA |
(2RS)-1-[3,4-(methylendioxy)fenyl]propan-2-amin |
|
Tenocyklidin |
TCP |
1-[1-(2-thienyl)cyklohexyl]piperidin |
|
TFMPP |
1-[3-(trifluormethyl)fenyl]piperazin |
||
Tetrahydrokanabinol |
THC |
Δ6a(10a)-,Δ6a(7)-,Δ7-,Δ8-,Δ10-,Δ9(11)-tetrahydrokanabinoly x xxxxxx xxxxxxxxxxxxx |
|
Xxxxxxxxxxxxxxxxxxx |
XXX |
(2XX)-1-(3,4,5-xxxxxxxxxxxxxxx)xxxxxx-2-xxxx |
|
Xxxxxxxxxxxxxxxxxxx-2 |
XXX-2 |
(2XX)-1-(2,4,5-xxxxxxxxxxxxxxx)xxxxxx-2-xxxx |
|
XX-144 |
(1-xxxxxx-1X-xxxxx-3-xx)-(2,2,3,3-xxxxxxxxxxxxxxxxxxxxxx)xxxxxxxx |
Xxxxxx xxxxxxxxxxxxx xxxxxxxxxxxxxx látek, xx na xxxxxxxx xxxxxxx, xxxxxxxxx x xxxxx xxxxxxx ve xxxxx případech, xxx xxxx xxxxxxxxxxxxx mohou xxxxxxxxx xxxxx xxxxxxxxxx xxxxxxxxxx xxxxxxxx a xxxx psychotropních xxxxx xxxxxxxxx x xxxxx xxxxxxx xx všech xxxxxxxxx, xxx mohou xxxxxxxxx.".
Xx. II
Toto xxxxxxxx xxxx xxxxxxxx x xxxxxxx xx směrnicí Xxxxxxxxxx xxxxxxxxxx x Xxxx 98/34/ES xx xxx 22. xxxxxx 1998 x xxxxxxx xxx poskytování informací x oblasti norem x xxxxxxxxxxx předpisů x předpisů pro xxxxxx xxxxxxxxxx xxxxxxxxxxx, x xxxxxxx xxxxx.
Xx. III
Účinnost
Toto nařízení xxxxxx xxxxxxxxx dnem 1. října 2015.
Předseda xxxxx:
Xxx. Xxxxxxx x. x.
&xxxx;Xxxxxxx zdravotnictví:
MUDr. Xxxxxxx, XXX, x. r.
Xxxxxxxxx
Xxxxxx xxxxxxx x. 243/2015 Sb. xxxxx xxxxxxxxx xxxx 1.10.2015.
Znění xxxxxxxxxxxx xxxxxxxx xxxxx xxxxxx xxxxxxxx předpisů x xxxxxxxx xxxx xxxxxxxxxxxxx, pokud se xxxx netýká xxxxxxxxx xxxxx xxxxx xxxxxxxxx xxxxxxxx xxxxxxxx.